Going forward..., page-4

Well, it did start at a fine institution rather than a garage...
But I have mentioned that comparison was possible a few years ago, and that's when I went long and accumulated...30c days.

As was the potential to grow into a CSL if we survived early TO

I find it astounding how long it has taken to have a follow up trial happening after GvHD has effectively taken nearly 5 years since RTO to complete a phase 1.

To just be "planning" for next one now (and get the Clearview report 2018) imo puts us in the slow lane compared to the stem cell sector and how fast things are moving.

Our biggest risk is this current management teams ability to execute and be focused on what matters and time.

The Tech and Business Model are fantastic.
Only reason many haven't sold the lot.